Back to Search
JACK GREINER, D.O.
D.O.
Ophthalmology Physician
NPI: 1588601280IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
56366(MA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Class of 1982
Research & Publications (20)
A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
PMID 15978305·Clin Ther·2005
3-trial
A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model.
PMID 12946546·Clin Ther·2003
3-trial
Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.
PMID 14644221·Am J Ophthalmol·2003
3-trial
Effects of fluorescein instillation methods on the tear film lipid layer.
PMID 12613953·Adv Exp Med Biol·2002
3-trial
Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.
PMID 18284627·Eur J Haematol·2008
6-review
Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells.
PMID 19010831·Clin Cancer Res·2008
6-review
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.
PMID 17145602·Haematologica·2006
6-review
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.
PMID 16931630·Blood·2006
3-trial
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.
PMID 15827130·Blood·2005
8-other
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
PMID 14696097·Int J Cancer·2004
4-observational
Evolution of the polarization of the optical afterglow of the gamma-ray burst GRB030329.
PMID 14614499·Nature·2003
8-other
Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.
PMID 12800198·Int J Cancer·2003
8-other
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
PMID 12225794·Exp Hematol·2002
8-other
Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.
PMID 12460911·Cancer Res·2002
7-preclinical
Simultaneous expression of different immunogenic antigens in acute myeloid leukemia.
PMID 11146163·Exp Hematol·2000
7-preclinical
Challenging complications of treatment--human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case report.
PMID 19619326·Virol J·2009
5-case
Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.
PMID 19638573·Cancer Res·2009
7-preclinical
Total synthesis and evaluation of 22-(3-azidobenzoyloxy)methyl epothilone C for photoaffinity labeling of beta-tubulin.
PMID 19428248·Bioorg Med Chem Lett·2009
8-other
The relationship between dry eye symptoms and lipid layer thickness.
PMID 19574906·Cornea·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 WHITTIER PL, STE 102 CHARLES RIVER EYE ASSOCIATES
BOSTON, MA 02114 - Phone
- (617) 248-3875
Quick Facts
- NPI
- 1588601280
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile